Electrolyte homeostasis pathway

Electrolyte homeostasis is a fundamental physiological process responsible for maintaining the precise concentrations of vital ions—such as sodium, potassium, calcium, and magnesium—and regulating fluid balance within the body [StatPearls: Physiology, Electrolytes]. This pathway is primarily managed by the renal system in conjunction with the endocrine system, utilizing hormones like aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide [Merck Manual: Overview of Electrolytes]. It involves a network of specialized proteins, including ion channels (e.g., ENaC), transporters (e.g., NKCC2, NCC), and G protein-coupled receptors (e.g., V2 receptor) [NIH: Fluid and Electrolyte Balance]. Dysregulation of this pathway leads to significant clinical conditions such as hypertension, heart failure, and various electrolyte imbalances like hyponatremia or hyperkalemia. While the pathway as a whole is not a single drug target, its individual components are the focus of numerous therapeutic classes, including diuretics, ACE inhibitors, and mineralocorticoid receptor antagonists. These interventions aim to restore balance by modulating the reabsorption or excretion of ions and water in the kidneys.

Other names

Water-electrolyte balanceMineral homeostasisIon homeostasisOsmoregulation

Drugs targeting this pathway typically act by inhibiting specific ion transporters in the nephron, antagonizing hormone receptors like the mineralocorticoid or vasopressin receptors, or inhibiting enzymes within the renin-angiotensin-aldosterone system to modulate salt and water retention.